| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1367702 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Abstract
Two novel side chains which had previously been found to enhance antagonist activity in the dihydrobenzoxathiin SERM series were applied to three existing platforms. The novel side chains did not improve the antagonist activity of the existing platforms.
Graphical abstractTwo novel side chains which had previously been found to enhance antagonist activity in the dihydrobenzoxathiin SERM series were applied to three existing platforms. The novel side chains did not improve the antagonist activity of the existing platforms.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Timothy A. Blizzard, Jerry D. Morgan II, Wanda Chan, Elizabeth T. Birzin, Lee-Yuh Pai, Edward C. Hayes, Carolyn A. DaSilva, Ralph T. Mosley, Yi Tien Yang, Susan P. Rohrer, Frank DiNinno, Milton L. Hammond,